VASOPRESSIN
| Brand name | VASOSTRICT |
|---|---|
| Active ingredient | VASOPRESSIN |
| Strength | 50UNITS/50ML (1UNITS/ML) |
| Dosage form | SOLUTION |
| Route | INTRAVENOUS |
| Modality | Small molecule |
| FDA approval | April 2023 |
| Marketing status | DISCN |
| Patent | Expires | Type |
|---|---|---|
| 9962422 | January 2035 | use U-1857 |
| 9981006 | January 2035 | use U-1857 |
| 9974827 | January 2035 | use U-1857 |
| 9968649 | January 2035 | use U-1857 |
| 9925233 | January 2035 | use U-1857 |
| 9925234 | January 2035 | use U-1857 |
| 10010575 | January 2035 | use U-1857 |
| 12186362 | January 2035 | product |
| 9919026 | January 2035 | product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.